問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberIM047-010
Completed

2022-08-01 - 2027-12-31

Phase III

Recruiting8

ICD-10K00.0

Anodontia

ICD-9520.0

Anodontia

  • Trial Applicant

    BRISTOL-MYERS SQUIBB (TAIWAN) LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Jen-Wei Chou Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 顏旭亨 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Cheng-Tang Chiu Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 凃佳宏 Division of General Internal Medicine

Co-Principal Investigator

  • 陳彥年 Division of General Internal Medicine
  • 陳介章 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 王彥博 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming-Yao Chen Division of General Internal Medicine

Co-Principal Investigator

  • 高碧珍 Division of General Internal Medicine
  • 賴雨欣 Division of General Internal Medicine
  • 林聖才 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator CHUNG-HSIN CHANG Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 黃天祐 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    24 participants

  • Global

    240 participants